Novel selective histone deacetylase 6 (HDAC6) inhibitors: a patent review (2016-2019)

X He, Z Li, XT Zhuo, Z Hui, T Xie… - Recent patents on anti …, 2020 - ingentaconnect.com
Background: Many human diseases are associated with dysregulation of HDACs. HDAC6
exhibits deacetylase activity not only to histone protein but also to non-histone proteins such …
被引用次数：24 相关文章

Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019)

X He, Z Li, XT Zhuo, Z Hui, T Xie, XY Ye - Recent Patents on Anti-Cancer …, 2020 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> Many human diseases are
associated with dysregulation of HDACs. HDAC6 exhibits deacetylase activity not only to …

Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019)

X He, Z Li, XT Zhuo, Z Hui, T Xie… - Recent patents on anti …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Many human diseases are associated with dysregulation of HDACs. HDAC6
exhibits deacetylase activity not only to histone protein but also to non-histone proteins such …

Novel Selective Histone Deacetylase 6 (HDAC6) Inhibitors: A Patent Review (2016-2019).

X He, Z Li, XT Zhuo, Z Hui, T Xie… - Recent Patents on Anti …, 2020 - europepmc.org
Background Many human diseases are associated with dysregulation of HDACs. HDAC6
exhibits deacetylase activity not only to histone protein but also to non-histone proteins such …